The WHO has added another four antiretrovirals from Ranbaxy Laboratories to its prequalification list

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.505, 2006-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health Canada's Therapeutic Products Directorate has granted manufacturing and marketing approval for tamsulosin 0.4mg capsules [Ranbaxy Laboratories].

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Cervarix vaccine [human papillomavirus vaccine MEDI-517] has been granted WHO prequalification in developing nations

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Ranbaxy has voluntarily recalled all lots of nitrofurantoin (monohydrate/macrocrystals) 100mg capsules from the US market

Reactions Weekly, Vol. 1, Iss. 1251, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Two abortifacient drugs have been added to WHO's list of essential drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

The UK MCA has added a new section on herbal safety to its website.

Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite